Association of the Arteriovenous Difference in Carbon Dioxide and Its Relation to the Difference in Arteriovenous Oxygen Content With the Occurrence of Postoperative Complication
CARBODAV
2 other identifiers
observational
90
1 country
1
Brief Summary
Intra-operative hemodynamic management in high-risk surgery is a priority for the anesthesiologist. The current strategy is based on the continuous measurement of cardiac output and its maximization by vascular filling has many limitations: invasiveness, measurement difficulties, impaired performance, imperative surgical restriction of filling, lack of evaluation of flow rate and metabolic needs. Biomarkers may be able to detect early an inadequacy between cardiac output and tissue oxygen requirements, venous saturation with oxygen (ScvO2) and arteriovenous difference in partial pressure of carbon dioxide (ΔPCO2) as well as the appearance of cellular hypoxia (lactate and arteriovenous difference in partial pressure of carbon dioxide/arteriovenous difference in oxygen) (ΔPCO2) / DAVO2). Moreover, the medical literature remains poor on the evaluation of these markers in per-operative context all the more for ΔPCO2 and ΔPCO2 / DAVO2. It seems interesting to evaluate the potential of these tools, in patients with major surgery and at high risk (major hepatectomy, oesophagectomy and duodeno-pancreatectomy), to predict the risk of postoperative complications, especially since surgery involves a restrictive vascular filling strategy that may be potentially deleterious to the patient.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 9, 2019
CompletedFirst Posted
Study publicly available on registry
April 16, 2019
CompletedStudy Start
First participant enrolled
May 9, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 19, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
November 19, 2020
CompletedAugust 29, 2022
August 1, 2022
1.5 years
April 9, 2019
August 26, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
mean intraoperative PCO2 values
PCO2 values will be collected every 2 hours during surgery
during surgery
mean postoperative PCO2 values
within 24 hours after surgery
post-operative complications
post-operative complications of grade III or greater according to Clavien-Dindo classification
28 days after surgery
Study Arms (1)
patient who will have a high risk digestive surgery
patient who will have a high risk digestive surgery: esophagectomy, major hepatectomy\> 3 segments, duodeno cephalic pancreatectomy
Interventions
The objective is to determine if there is an association between the mean intraoperative values and within 24 hours postoperative ΔPCO2 and the occurrence of major post-operative complications at day 28 in high-risk surgery (major hepatectomy, esophagectomy or duodeno- cephalic pancreatectomy)
Eligibility Criteria
The study concerns patients operated for a high-risk digestive surgery, hospitalized postoperatively in intensive care unit (agreed in anesthesia consultation). These patients will also need to have an arterial catheter and a central venous line in the superior vena cava
You may qualify if:
- Major patient
- Patient eligible for a high risk scheduled gastrointestinal surgery from:
- Esophagectomy
- Major hepatectomy (≥ 3 segments)
- Cephalic duodeno-pancreatectomy Patient with an arterial catheter and a central venous line in superior vena cava.
- Patient hospitalized post-operatively in intensive care unit as agreed in consultation with preoperative anesthesia.
You may not qualify if:
- Pregnant or lactating patients
- Patient with an unstable acute condition at the time of surgery (acute heart, respiratory or renal failure, severe sepsis or septic shock, hemorrhagic shock)
- Patient opposing his participation in the study
- Patient protected by law (guardianship)
- Patient deprived of liberty
- Patient with a contraindication to the establishment of a central venous route in superior vena cava territory or a radial or femoral arterial catheter
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hôpital de la Croix Rousse
Lyon, 69004, France
Related Publications (1)
Guilherme E, Delignette MC, Pambet H, Lebreton T, Bonnet A, Pradat P, Boucheny C, Guichon C, Aubrun F, Gazon M. PCO2 gap, its ratio to arteriovenous oxygen content, ScvO2 and lactate in high-risk abdominal surgery patients: An observational study. Anaesth Crit Care Pain Med. 2022 Apr;41(2):101033. doi: 10.1016/j.accpm.2022.101033. Epub 2022 Feb 14.
PMID: 35176527DERIVED
Biospecimen
It was estimated that there is between 40 and 60 ml of blood taken during this kind of intervention and in 24-hour postoperative intervention . The completion of the study should result in an increase in blood volume taken from 5 to 10 mL
Study Officials
- PRINCIPAL INVESTIGATOR
Mathieu GAZON
Hospices Civils de Lyon
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 9, 2019
First Posted
April 16, 2019
Study Start
May 9, 2019
Primary Completion
November 19, 2020
Study Completion
November 19, 2020
Last Updated
August 29, 2022
Record last verified: 2022-08